Twelve-week Monotherapy with the DPP-4 Inhibitor Vildagliptin Improves Glycemic Control in Subjects with Type 2 Diabetes - Pratley, R E; Jauffret-Kamel, S; Galbreath, E; Holmes, D (Hormone and Metabolic Research, 2006)